Thanks, Damien, and good morning. On Page 8, you’ll see a summary of our fourth quarter 2024 financial results. We generated adjusted EBITDA of $38 million. This is a material improvement over the prior year fourth quarter despite an estimated $7 million impact from the planned turnaround we completed at our Cherokee facility’s ammonia plant in December. Page 9 provides some color to the quarter-over-quarter results by bridging our fourth quarter 2023 adjusted EBITDA of $25 million to our fourth quarter 2024 adjusted EBITDA of $38 million. Stronger sales volumes from improvements in plant reliability, higher ammonia prices and lower natural gas costs benefited us during the period. Notably, excluding the sales volume impact of our Cherokee turnaround, we estimate that our fourth quarter adjusted EBITDA would have been approximately $45 million. These financial results reflect the positive impact of the work that we completed during 2024 to improve our manufacturing operations. We expect to make further progress on this front in 2025, as I will discuss shortly. Page 10 provides a summary of our key balance sheet and cash flow metrics. Our cash flow balance remains strong, and our 2024 year-end leverage ratio was below our target level for a mid-cycle pricing environment. At the same time, we’ve made significant investments in the reliability of our facilities as well as in capacity expansion, storage and logistics capabilities. Much of this investment is reflected in our $92 million of CapEx for the full year 2024, of which approximately $25 million was targeted towards growth, with the balance to sustain reliable operations. In addition to investing in our manufacturing assets over the 2 years ended December 31, 2024, we derisked our balance sheet by repurchasing approximately $222 million in principal amount of our senior secured notes. We also returned capital to stockholders through the repurchase of approximately 4.6 million shares of our stock in the same period. Slide 11 summarizes the key considerations with respect to our expectations for full year 2025. The table in the upper left shows our estimated ammonia production and sales volumes for the year. We expect that our ammonia production will increase as compared to 2024 with the improvements made in the turnarounds we completed at our Pryor and Cherokee facilities last year. This production should more than offset the impact of the 30-day turnaround planned at our El Dorado site during the second half of this year. Also, we expect the work completed in 2024 to yield meaningful increases in production and sales volumes of our downstream products, AN, nitric acid and UAN. At the same time, you can see that we expect our ammonia sales volumes to decline in 2025, reflecting the upgrade of a greater portion of our ammonia production into higher-margin downstream products. The slide also covers our estimates of variable and fixed plant expenses as well as SG&A and other expenses for 2025. Our expectations for fixed costs reflect investments we are making to achieve our production volume goals. We expect to see fixed costs trend down beginning in 2026. We expect our effective tax rate for the year to be approximately 25%. However, we do not expect to be a material cash taxpayer in 2025 as we continue to utilize our NOLs. In the table at the bottom right side of the slide, you’ll see that we expect to invest approximately $80 million to $90 million of CapEx in our facilities during 2025. That includes $60 million to $65 million for annual EH&S and reliability CapEx and $20 million to $25 million earmarked for growth investments, including enhanced logistics and storage capabilities for our growing AN business. As Damien pointed out, urea prices are rising in the U.S., resulting in a corresponding rise in UAN pricing, a trend we believe will continue through the forthcoming spring application season. We expect our first quarter volumes to be relatively flat compared to the first quarter of 2024. This is largely the result of lower inventory levels heading into 2025 following our turnarounds in the final months of the year. With that said, as indicated on this slide, we do expect a volume uplift for the full year 2025. Through the first 2 months of the year, our cost of gas has averaged approximately $3.85 per MMBtu. This is consistent with our expectations for 2025 natural gas prices to be higher relative to 2024. We previously discussed our focus on upgrading an increasing amount of ammonia to capture additional margins. Page 12 illustrates the favorable sales volume trends we’re driving in our major product groups adjusted for the impact of turnarounds. The first chart shows the increase in AN and nitric acid sales volumes recognized in 2024 as a result of our reliability improvements to our downstream operations and the full year volume impact we expect in 2025. The middle chart shows UAN sales volumes, which, despite the impact of turnarounds at both our Pryor and Cherokee facilities, were flat in ‘24 compared to ‘23. This strong performance results in part from the urea expansion we completed at our Pryor facility in the third quarter. Excluding the impact of turnarounds shown in the white and blue striped section of the middle bar, we estimate that UAN sales volumes would have been up significantly. Our projection for a further increase in UAN volume in 2025 reflects the full year benefit of the new capacity as well as improved plant reliability. The chart on the far right shows a downward trend in ammonia sales volumes. In this case, a down into the right trend is a good thing. Turning to Page 13, you’ll find a summary of the multiple initiatives we have underway to drive earnings growth. First, over the course of 2024, we talked about our two margin enhancement projects, the expansion of our urea capacity at our Pryor facility that we expect to allow us to produce an incremental 75,000 tons of UAN annually and the construction of an additional 5,000 tons of nitric acid storage at our El Dorado facility. Both projects were completed in the second half of 2024. We expect to see the full year incremental EBITDA benefit in 2025. Second, our stated goal of increasing our ammonia production volumes represents an important earnings lever. And while we recognize some of those benefits post the work performed during the 2024 turnaround, we have additional opportunity ahead of us. We expect the turnaround of our El Dorado ammonia plant in the second half of this year to move us further towards our ammonia production goals. Third, during 2024, we put a great deal of focus on improving the reliability of our downstream production. We are pleased with our progress in 2024 and have ongoing initiatives to capture additional production that we expect to see in 2025. Lastly, we believe we can generate meaningful incremental earnings by driving efficiencies and focusing on profit optimization. There are numerous opportunities to realize efficiencies in our business and capturing them will be a focus for 2025. Additionally, our spending levels have been elevated over the past several years as we’ve made investments aimed at increasing production and maximizing sales volumes. We expect these costs to reach an inflection point in 2025 and begin trending downward in 2026. One additional point to keep in mind is that on top of these value creation activities, we also have the expectation of $15 million to $20 million of incremental annual EBITDA once we have our CCS project at our El Dorado facility complete. And now I’ll turn it back over to Mark.